City-Dwelling Women at Greater Risk for Breast Cancer

Publication
Article
OncologyONCOLOGY Vol 21 No 14
Volume 21
Issue 14

Women who live in urban areas have denser breasts, making them more likely to develop breast cancer, according to a study presented recently at the annual meeting of the Radiological Society of North America (RSNA).

Women who live in urban areas have denser breasts, making them more likely to develop breast cancer, according to a study presented recently at the annual meeting of the Radiological Society of North America (RSNA).

"Women living in cities need to pay more attention to having regular breast screening," said Nicholas M. Perry, mbbs, frcs, frcr, director of the London Breast Institute at the Princess Grace Hospital in London, UK. "Currently, women who live in urban areas are known to have lower attendance for breast screening programs than women in outlying areas."

Breast tissue in women may be fatty or glandular or a mixture of both. Women with more glandular breasts show denser tissue on a mammogram and are known to have nearly four times the risk of developing breast cancer than women with fatty breasts. Dr. Perry and colleagues set out to determine if there was a relationship between breast density and area of residence.

More Research Needed

The researchers analyzed digital mammograms of 972 women from urban, suburban, and rural areas. They discovered that women who lived in London had significantly denser breasts than those living outside the city. The risk of increased density was twice as great in the 45- to 54-year-old group. Age-specific analyses suggested that overall differences by area were more pronounced in women under age 50.

Dr. Perry cautioned that more research is needed to determine the precise reason for this phenomenon, taking into account lifestyle factors, stress, workplace, and other possible contributors, but he advised that all women maintain a recommended breast screening regimen, and that women with dense breasts be screened with digital mammography, which is more effective at detecting cancer in dense breast tissue.

"Regular breast screening with mammography saves lives," Dr. Perry said. "Access to breast screening for women living in cities must be prioritized."

Recent Videos
Breast cancer care providers make it a goal to manage the adverse effects that patients with breast cancer experience to minimize the burden of treatment.
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
Antibody-drug conjugates are effective, but strategies such as better understanding the mechanisms of action may lead to enhanced care for patients with cancer. Antibody-drug conjugates are effective, but strategies such as better understanding the mechanisms of action may lead to enhanced care for patients with cancer.
ADCs demonstrate superior efficacy vs chemotherapy but maintain a similar efficacy profile that requires multidisciplinary collaboration to optimally treat.
According to Aditya Bardia, MD, MPH, FASCO, antibody-drug conjugates are slowly replacing chemotherapy as a standard treatment for breast cancer.
Administering oral SERD-based regimens may enhance patients’ quality of life when undergoing treatment for ER-positive, HER2-negative breast cancer.
Gedatolisib-based triplet regimens may be effective among patients with prior endocrine resistance or rapid progression following frontline therapy.
Leading experts in the breast cancer field highlight the use of CDK4/6 inhibitors, antibody-drug conjugates, and other treatment modalities.
Related Content